ArticleBlood research2022

Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea.

Seo-Yeon Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.